“Blockbuster” Launch Model Changing, Pfizer Says; Still Hope For Caduet
Executive Summary
Successful pharmaceutical launches are no longer determined by first-year performance, Pfizer CEO Hank McKinnell suggested during a July 21 conference call
You may also be interested in...
Pfizer’s New Benchmark For New Era: 8% Annual Growth Is Sustainable
The pharmaceutical industry is entering a period where average annual growth rates are likely to hover at about 8%, Pfizer CEO Hank McKinnell predicted during a Nov. 30 analyst meeting in Groton, Conn
Pfizer’s New Benchmark For New Era: 8% Annual Growth Is Sustainable
The pharmaceutical industry is entering a period where average annual growth rates are likely to hover at about 8%, Pfizer CEO Hank McKinnell predicted during a Nov. 30 analyst meeting in Groton, Conn
Pfizer Confident That Caduet Will Succeed; How Safe Is Sales Force?
Pfizer hopes that a rewording of the indications section for Caduet will help the combination product live up to the company's expectations